Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Bosier

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Trends in Pharmacological Sciences|July 17, 2007
Versatility of GPCR recognition by drugs: from biological implications to therapeutic relevanceBarbara Bosier, Emmanuel Hermans
FEBS Letters|October 28, 2008
Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E-115 cellsBarbara Bosier, Didier M Lambert, Emmanuel Hermans
Biochemical Pharmacology|November 11, 2008
Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB(1) cannabinoid receptor agonists on tyrosine hydroxylase expressionBarbara Bosier, Emmanuel Hermans, Didier M Lambert
British Journal of Pharmacology|September 14, 2012
The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanismsBarbara Bosier, Giulio G Muccioli, Didier M Lambert
Biochemical Pharmacology|March 9, 2010
Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunitiesBarbara Bosier, Giulio G Muccioli, Emmanuel Hermans, et al.
Journal of Neurochemistry|June 2, 2007
Agonist selective modulation of tyrosine hydroxylase expression by cannabinoid ligands in a murine neuroblastoma cell lineBarbara Bosier, Sébastien Tilleux, Mustapha Najimi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 30, 2011
Increasing the density of the D2L receptor and manipulating the receptor environment are required to evidence the partial agonist properties of aripiprazoleBeryl Koener, Marylène C Focant, Barbara Bosier, et al.
Neuropharmacology|July 17, 2010
Revisiting the complex influences of cannabinoids on motor functions unravels pharmacodynamic differences between cannabinoid agonistsBarbara Bosier, Sophie Sarre, Ilse Smolders, et al.
Synapse (New York, N.Y.)|March 27, 2010
Influence of chronic bromocriptine and levodopa administration on cerebral type 1 cannabinoid receptor bindingCindy Casteels, Bert Vanbilloen, Dorien Vercammen, et al.
Neuropharmacology|February 28, 2012
Differential modulations of striatal tyrosine hydroxylase and dopamine metabolism by cannabinoid agonists as evidence for functional selectivity in vivoBarbara Bosier, Giulio G Muccioli, Birgit Mertens, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Trends in Pharmacological Sciences|July 17, 2007
Versatility of GPCR recognition by drugs: from biological implications to therapeutic relevanceBarbara Bosier, Emmanuel Hermans
FEBS Letters|October 28, 2008
Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E-115 cellsBarbara Bosier, Didier M Lambert, Emmanuel Hermans
Biochemical Pharmacology|November 11, 2008
Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB(1) cannabinoid receptor agonists on tyrosine hydroxylase expressionBarbara Bosier, Emmanuel Hermans, Didier M Lambert
British Journal of Pharmacology|September 14, 2012
The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanismsBarbara Bosier, Giulio G Muccioli, Didier M Lambert
Biochemical Pharmacology|March 9, 2010
Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunitiesBarbara Bosier, Giulio G Muccioli, Emmanuel Hermans, et al.
Journal of Neurochemistry|June 2, 2007
Agonist selective modulation of tyrosine hydroxylase expression by cannabinoid ligands in a murine neuroblastoma cell lineBarbara Bosier, Sébastien Tilleux, Mustapha Najimi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 30, 2011
Increasing the density of the D2L receptor and manipulating the receptor environment are required to evidence the partial agonist properties of aripiprazoleBeryl Koener, Marylène C Focant, Barbara Bosier, et al.
Neuropharmacology|July 17, 2010
Revisiting the complex influences of cannabinoids on motor functions unravels pharmacodynamic differences between cannabinoid agonistsBarbara Bosier, Sophie Sarre, Ilse Smolders, et al.
Synapse (New York, N.Y.)|March 27, 2010
Influence of chronic bromocriptine and levodopa administration on cerebral type 1 cannabinoid receptor bindingCindy Casteels, Bert Vanbilloen, Dorien Vercammen, et al.
Neuropharmacology|February 28, 2012
Differential modulations of striatal tyrosine hydroxylase and dopamine metabolism by cannabinoid agonists as evidence for functional selectivity in vivoBarbara Bosier, Giulio G Muccioli, Birgit Mertens, et al.
Pageof 2